Medicase

Asking

$6K

Annual revenue

$684

Annual profit

—

SDE multiple

8.0x

💻 OnlineSaasSource: catchbuys:trustmrr

The thesis

Pass. The SDE multiple of 8.04 is above the acceptable threshold of 4x.

🚩 Red flags

•annual_profit is 0, indicating no cash flow generation.
•SDE multiple of 8.04 is above the 4x threshold.

Medicase is a SaaS business in the education sector, currently listed for sale at $5,500. It generates $57 in monthly revenue, totaling $684 annually.

The business has an annual profit of $0, indicating it is not generating cash flow at this time. The SDE multiple is 8.04, which is above the typical threshold for attractive acquisitions.

This opportunity may appeal to buyers looking for low-cost entry points, but the lack of profitability and high multiple raises concerns.

Potential buyers should conduct thorough due diligence, particularly around cash flow and operational sustainability, before proceeding.

Ready to make a move?

LamboApp surfaces the deal. The broker holds the intake. Do your own diligence — our fit score is a starting point, not a green light.

View listing on trustmrr.com →← See more deals

Not financial advice. LamboApp scrapes public broker listings, runs Claude Haiku across them, and surfaces the ones our rubric ranks highly. The thesis, red flags, and growth signals are AI-generated from the listing text alone. Numbers come from the broker (unverified). Do your own diligence, hire a lawyer, hire an accountant, don’t wire until an LOI + QoE clears.